Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Current Protocols in Pharmacology|September 22, 2011
In vitro anti-hepatitis C virus (HCV) resistance selection and characterizationHongmei MoVirology|April 4, 2021
A primary human hepatocyte/hepatic stellate cell co-culture system for improved in vitro HBV replicationBin Han, Hongmei Mo, Evguenia Svarovskaia, et al.Antimicrobial Agents and Chemotherapy|March 21, 2007
Evolution of resistant M414T mutants among hepatitis C virus replicon cells treated with polymerase inhibitor A-782759Liangjun Lu, Hongmei Mo, Tami J Pilot-Matias, et al.International Medical Case Reports Journal|August 19, 2025
Severe Plasmodium Falciparum Malaria Mimicking Thrombotic Thrombocytopenic Purpura (TTP): A Case Report From ChinaCheng Wang, Man Kong, Ming Huang, et al.Antiviral Research|September 10, 2013
Development and characterization of a replicon-based phenotypic assay for assessing HCV NS4B from clinical isolatesSonal Rajyaguru, Huiling Yang, Ross Martin, et al.Journal of Clinical Microbiology|September 15, 2004
Complementation in cells cotransfected with a mixture of wild-type and mutant human immunodeficiency virus (HIV) influences the replication capacities and phenotypes of mutant variants in a single-cycle HIV resistance assayHongmei Mo, Liangjun Lu, Ron Pithawalla, et al.Frontiers in Oncology|June 21, 2024
The effects of postoperative targeted immunotherapy on peripheral blood cytokines and immune cell profile in lung cancer patientsChuang Zhang, Hongmei Mo, Min Li, et al.Virology|May 1, 2012
Tegobuvir (GS-9190) potency against HCV chimeric replicons derived from consensus NS5B sequences from genotypes 2b, 3a, 4a, 5a, and 6aKelly A Wong, Simin Xu, Ross Martin, et al.Journal of Viral Hepatitis|September 7, 2020
Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistanceYang Liu, Silvia Chang, Ross Martin, et al.Journal of Clinical Microbiology|July 28, 2012
Abundant drug-resistant NS3 mutants detected by deep sequencing in hepatitis C virus-infected patients undergoing NS3 protease inhibitor monotherapyEvguenia S Svarovskaia, Ross Martin, John G McHutchison, et al.Pageof 13